Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04975633 · ClinicalTrials.gov registry record · NA

USC and Bodyport Remote Heart Failure Management Study

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT04975633: Completed NA study, sponsored by University of Southern California.

NCT04975633 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04975633, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

A feasibility study investigating the Bodyport virtual cardiac clinic vs usual care for outpatient heart failure management at Keck Medical Center of USC

Primary Outcome

Evaluating Kansas City Cardiomyopathy Questionnaire (KCCQ) measurements at the time of hospital discharge and 90-days post-discharge

Interventions

  • DEVICE Bodyport Cardiac Scale

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2021-05-10
Est. Completion 2024-09-05
Phase NA
University of Southern California

617 total trials

What the finished NCT04975633 record still lists

NCT04975633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Bodyport Cardiac Scale is the first listed.

NCT04975633 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04975633 about?

NCT04975633 is a clinical study titled "USC and Bodyport Remote Heart Failure Management Study". A feasibility study investigating the Bodyport virtual cardiac clinic vs usual care for outpatient heart failure management at Keck Medical Center of USC

What is the current status of trial NCT04975633?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2021-05-10. Estimated completion is 2024-09-05.

What interventions are being tested in trial NCT04975633?

The interventions under investigation include: Bodyport Cardiac Scale (DEVICE).

Who is sponsoring clinical trial NCT04975633?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04975633's enrollment target sits among peer trials

39 1536th of 2000 higher than 463 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04975633, the US trial registry maintained by the National Library of Medicine. NCT04975633 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.